Sotorasib靶向治疗KRAS G12C突变晚期实体肿瘤的疗效及安全性

    Efficacy and Safety of Sotorasib in Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

    /

    返回文章
    返回